Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 CHF | +6.59% | -15.38% | +34.15% |
Apr. 17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
Apr. 17 | Swiss Court OKs Moratorium Extension for Spexis | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.15% | 4.09M | |
-5.99% | 83.66B | |
+2.76% | 40.41B | |
-24.88% | 28.26B | |
+53.61% | 24.53B | |
-8.08% | 16.82B | |
-33.74% | 13.39B | |
-16.63% | 11.75B | |
-11.19% | 11.69B | |
-2.25% | 8.13B |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- Polyphor To Close EnBiotix Merger Before 2021-End